Effect of intrathecal agmatin on hyperalgesia and spinal dorsal NMDA receptor 1 expression in mice with bone cancer pain
Zhong Ji-yin
Abstract
Zhong Ji-yin
Abstract
Objective To investigate the effect of intrathecal agmatin on hyperalgesia and spinal dorsal NMDA receptor 1 expression in mice with bone cancer pain. Methods Fifty-six adult female SD rats weighing 180-220 g were randomly divided into 4 groups with 14 each: sham operation group(group A); bone cancer group(group B); control group(group C); agmatin group(group D). Group C and D received intrathecal injection with 10 ul saline or 160 mg/kg agmatin. Mechanical paw withdrawal latencies(MWT) was measured by von Frey silk. The expression of NR1 was investigated 120 min after intrathecal agmatin treatment.Results MWT was significantly decreased in group B,C, D than group A 7 days after successful bone cancer pain model building(P0.05). MWT was higher in group D than group B and C(P0.05). The expression of NR1 was increased in group B,C,D than group A(P0.05). The expression of NR1 was lower in group D than group B and C(P0.05).Conclusion This study shows that agmatin may be involved in the mechanism of bone cancer pain through NMDA receptor.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of intrathecal agmatin on hyperalgesia and spinal dorsal NMDA receptor 1 expression in mice with bone cancer pain. Methods Fifty-six adult female SD rats weighing 180-220 g were randomly divided into 4 groups with 14 each: sham operation group(group A); bone cancer group(group B); control group(group C); agmatin group(group D). Group C and D received intrathecal injection with 10 ul saline or 160 mg/kg agmatin. Mechanical paw withdrawal latencies(MWT) was measured by von Frey silk. The expression of NR1 was investigated 120 min after intrathecal agmatin treatment.Results MWT was significantly decreased in group B,C, D than group A 7 days after successful bone cancer pain model building(P0.05). MWT was higher in group D than group B and C(P0.05). The expression of NR1 was increased in group B,C,D than group A(P0.05). The expression of NR1 was lower in group D than group B and C(P0.05).Conclusion This study shows that agmatin may be involved in the mechanism of bone cancer pain through NMDA receptor.
Key concepts: Medicine, Bone cancer, Intrathecal, NMDA receptor, Hyperalgesia, Saline, Anesthesia, Cancer pain